{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:41:08Z","timestamp":1790862068228,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.lfs.2021.119218","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T00:58:44Z","timestamp":1613350724000},"page":"119218","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["High chemokine ligand 11 levels in nasal lavage fluid: A potential predictor of and therapeutic target for murine eosinophilic chronic rhinosinusitis"],"prefix":"10.1016","volume":"271","author":[{"given":"Xiang","family":"Ren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.lfs.2021.119218_bb0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.amjoto.2018.03.020","article-title":"Nasal polyposis pathophysiology: endotype and phenotype open issues","volume":"39","author":"Brescia","year":"2018","journal-title":"Am. J. Otolaryngol."},{"issue":"5","key":"10.1016\/j.lfs.2021.119218_bb0010","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jaci.2008.07.008","article-title":"Different types of T-effector cells orchestrate mucosal inflammation in chronic sinus disease","volume":"122","author":"Zhang","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"issue":"11","key":"10.1016\/j.lfs.2021.119218_bb0015","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1007\/s00405-017-4717-2","article-title":"Development of a mouse model of eosinophilic chronic rhinosinusitis with nasal polyp by nasal instillation of an Aspergillus protease and ovalbumin","volume":"274","author":"Kim","year":"2017","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119218_bb0020","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00405-016-4260-6","article-title":"The role of IL-25 and IL-33 in chronic rhinosinusitis with or without nasal polyps","volume":"274","author":"Ozturan","year":"2017","journal-title":"Eur. Arch. Otorhinolaryngol."},{"key":"10.1016\/j.lfs.2021.119218_bb0025","doi-asserted-by":"crossref","first-page":"930","DOI":"10.3389\/fimmu.2019.00930","article-title":"Group 2 innate lymphoid cells in respiratory allergic inflammation","volume":"10","author":"Helfrich","year":"2019","journal-title":"Front. Immunol."},{"issue":"7672","key":"10.1016\/j.lfs.2021.119218_bb0030","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/nature24029","article-title":"The neuropeptide NMU amplifies ILC2s-driven allergic lung inflammation","volume":"549","author":"Wallrapp","year":"2017","journal-title":"Nature"},{"issue":"6393","key":"10.1016\/j.lfs.2021.119218_bb0035","doi-asserted-by":"crossref","DOI":"10.1126\/science.aan8546","article-title":"Pulmonary neuroendocrine cells amplify allergic asthma responses","volume":"360","author":"Sui","year":"2018","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.lfs.2021.119218_bb0040","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1439-0264.2004.00532.x","article-title":"Sirius red is able to selectively stain eosinophil granulocytes in bovine, ovine and equine cervical","volume":"33","year":"2004","journal-title":"Anat. Histol. Embryol."},{"issue":"6","key":"10.1016\/j.lfs.2021.119218_bb0045","doi-asserted-by":"crossref","first-page":"e255","DOI":"10.2500\/ajra.2011.25.3727","article-title":"Staphylococcus aureus enterotoxin B contributes to induction of nasal polypoid lesions in an allergic rhinosinusitis murine model","volume":"25","author":"Kim","year":"2011","journal-title":"Am. J. Rhinol. Allergy"},{"issue":"1","key":"10.1016\/j.lfs.2021.119218_bb0050","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41423-018-0182-0","article-title":"Kinetics of the accumulation of group 2 innate lymphoid cells in IL-33-induced and IL-25-induced murine models of asthma: a potential role for the chemokine CXCL16","volume":"16","author":"Li","year":"2019","journal-title":"Cell Mol. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119218_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjoto.2020.102795","article-title":"Structured histopathology for endotyping and planning rational treatment in chronic rhinosinusitis","volume":"42","author":"Brescia","year":"2021","journal-title":"Am. J. Otolaryngol."},{"issue":"11","key":"10.1016\/j.lfs.2021.119218_bb0060","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1002\/alr.22214","article-title":"Highlights of eosinophilic chronic rhinosinusitis with nasal polyps in definition, prognosis, and advancement","volume":"8","author":"Lou","year":"2018","journal-title":"Int. Forum Allergy Rhinol."},{"issue":"10","key":"10.1016\/j.lfs.2021.119218_bb0065","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1007\/s00405-017-4547-2","article-title":"Biomarkers in the evaluation and management of chronic rhinosinusitis with nasal polyposis","volume":"274","author":"Yao","year":"2017","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"5","key":"10.1016\/j.lfs.2021.119218_bb0070","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1177\/1945892418793523","article-title":"Prognosis of chronic rhinosinusitis with nasal polyps using preoperative eosinophil\/basophil levels and treatment compliance","volume":"32","author":"Guo","year":"2018","journal-title":"Am. J. Rhinol. Allergy"},{"issue":"3","key":"10.1016\/j.lfs.2021.119218_bb0075","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jaci.2017.01.022","article-title":"Microparticles in nasal lavage fluid in chronic rhinosinusitis: potential biomarkers for diagnosis of aspirin-exacerbated respiratory disease","volume":"140","author":"Takahashi","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"4","key":"10.1016\/j.lfs.2021.119218_bb0080","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jaci.2011.05.013","article-title":"The effects of an anti-IL-13 mAb on cytokine levels and nasal symptoms following nasal allergen challenge","volume":"128","author":"Nicholson","year":"2011","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119218_bb0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.alit.2018.09.005","article-title":"Reduced nasal nitric oxide levels in patients with eosinophilic chronic rhinosinusitis","volume":"68","author":"Yoshida","year":"2019","journal-title":"Allergol. Int."},{"key":"10.1016\/j.lfs.2021.119218_bb0090","doi-asserted-by":"crossref","first-page":"74","DOI":"10.3389\/fimmu.2019.00074","article-title":"Eotaxin-3 as a plasma biomarker for mucosal eosinophil infiltration in chronic rhinosinusitis","volume":"10","author":"Yamada","year":"2019","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.lfs.2021.119218_bb0095","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/lary.20191","article-title":"Eotaxin-1, -2, and -3 immunoreactivity and protein concentration in the nasal polyps of eosinophilic chronic rhinosinusitis patients","volume":"119","author":"Yao","year":"2009","journal-title":"Laryngoscope"},{"issue":"8","key":"10.1016\/j.lfs.2021.119218_bb0100","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s00405-019-05465-x","article-title":"Multiple airborne allergen-induced eosinophilic chronic rhinosinusitis murine model","volume":"276","author":"Park","year":"2019","journal-title":"Eur. Arch. Otorhinolaryngol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119218_bb0105","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.jaci.2015.04.041","article-title":"Eosinophil extracellular trap cell death-derived DNA traps: their presence in secretions and functional attributes","volume":"137","author":"Ueki","year":"2016","journal-title":"J. Allergy Clin. Immunol."},{"issue":"2","key":"10.1016\/j.lfs.2021.119218_bb0110","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.alit.2020.02.002","article-title":"The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis","volume":"69","author":"Nagase","year":"2020","journal-title":"Allergol. Int."},{"issue":"11","key":"10.1016\/j.lfs.2021.119218_bb0115","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1182\/blood-2012-05-432088","article-title":"Eosinophil extracellular DNA trap cell death mediates lytic release of free secretion-competent eosinophil granules in humans","volume":"121","author":"Ueki","year":"2013","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.lfs.2021.119218_bb0120","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/s12276-018-0136-8","article-title":"Biological function of eosinophil extracellular traps in patients with severe eosinophilic asthma","volume":"50","author":"Choi","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"3","key":"10.1016\/j.lfs.2021.119218_bb0125","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11882-006-0036-1","article-title":"Differential diagnosis of eosinophilic chronic rhinosinusitis","volume":"6","author":"Sok","year":"2006","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"10.1016\/j.lfs.2021.119218_bb0130","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1164\/rccm.201410-1793OC","article-title":"Prostaglandin I2 signaling and inhibition of group 2 innate lymphoid cell responses","volume":"193","author":"Zhou","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"5","key":"10.1016\/j.lfs.2021.119218_bb0135","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1016\/j.jaci.2017.11.043","article-title":"Glucagon-like peptide 1 signaling inhibits allergen-induced lung IL-33 release and reduces group 2 innate lymphoid cell cytokine production in vivo","volume":"142","author":"Toki","year":"2018","journal-title":"J. Allergy Clin. Immunol."},{"issue":"1","key":"10.1016\/j.lfs.2021.119218_bb0140","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.clim.2014.09.007","article-title":"Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness","volume":"155","author":"Walford","year":"2014","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.lfs.2021.119218_bb0145","doi-asserted-by":"crossref","first-page":"E265","DOI":"10.1002\/lary.26004","article-title":"Prolonged allergen exposure is associated with increased thymic stromal lymphopoietin expression and type2-skewing in mouse models of chronic rhinosinusitis","volume":"126","author":"Kim","year":"2016","journal-title":"Laryngoscope"},{"key":"10.1016\/j.lfs.2021.119218_bb0150","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.3389\/fimmu.2018.02330","article-title":"Enhanced interferon-beta response contributes to eosinophilic chronic rhinosinusitis","volume":"9","author":"Jang","year":"2018","journal-title":"Front. Immunol."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521002034?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320521002034?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:46:23Z","timestamp":1758401183000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320521002034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":30,"alternative-id":["S0024320521002034"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119218","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High chemokine ligand 11 levels in nasal lavage fluid: A potential predictor of and therapeutic target for murine eosinophilic chronic rhinosinusitis","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2021.119218","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"119218"}}